LakeShore Biopharma Co., Ltd
LSBNASDAQHealthcare
$0.63
+$0.00(+0.00%)
Market Cap$25840359
P/E Ratio—
52W High$8.6
52W Low$0.574
LakeShore Biopharma Co., Ltd（LSB）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · LSB · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.10B) | ($0.43B) | ($0.15B) | ($0.11B) | ($0.21B) |
| Depreciation & Amort. | $0.04B | $0.04B | $0.04B | $0.03B | $0.03B |
| Stock-Based Comp. | $0.01B | $0.01B | $0.00B | $0.01B | $0.08B |
| Change in Working Capital | ($0.12B) | ($0.05B) | ($0.09B) | ($0.14B) | ($0.15B) |
| Net Cash from Operations | ($0.12B) | ($0.30B) | ($0.18B) | ($0.17B) | ($0.25B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.02B) | ($0.04B) | ($0.06B) | ($0.30B) | ($0.10B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.02B) | ($0.04B) | ($0.06B) | ($0.30B) | ($0.10B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.00B) | ($0.08B) | $0.10B | $0.36B | $0.01B |
| Net Cash from Financing | ($0.00B) | $0.21B | $0.32B | $0.36B | $0.74B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.14B) | ($0.34B) | ($0.24B) | ($0.30B) | ($0.35B) |
| FCF Margin %(computed) | -22.58% | -59.20% | -34.85% | -59.56% | -136.76% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · CNY · B
深入了解LakeShore Biopharma Co., Ltd
关于LakeShore Biopharma Co., Ltd（LSB）现金流量表
LakeShore Biopharma Co., Ltd 2025财年经营活动现金流($0.12B)，自由现金流($0.14B)（FCF利润率-22.58%），资本支出($0.02B)。
常见问题
LSB · 4 问LakeShore Biopharma Co., Ltd 2025财年自由现金流($0.14B)，同比up59.1%。
LSB free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10